Skip to content
healthcare.dev

Doxazosin mesylate

NDC 62135-051, Doxazosin mesylate, tablet, from Chartwell RX, LLC.

Product NDC
62135-051
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075646
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-051 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE1 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
62135-051-906213500519090 TABLET in 1 BOTTLE (62135-051-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a7f589b0-eebb-48cb-912f-a4bd956e4dcb
  • NADAC price for package 62135005190

    GET /v1/drugs/nadac/62135005190

Use it

Look up 62135-051 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-051 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-051. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.